Source comparison
CJC-1295 no DAC & Ipamorelin vs GHRP-6 Acetate: Research Application Comparison
CJC-1295 no DAC + Ipamorelin Dual-axis: GHRH analog extends pulse duration + selective GHS amplifies pulse amplitude Sustained 2–4 hour elevation, 2–4 ng/mL mean increase, youth-pattern pulse mimicry Minimal. No significant cortisol or prolactin co-secretion a
This comparison does not assign a generated winner or score.
- CJC-1295 no DAC + Ipamorelin
- Dual-axis: GHRH analog extends pulse duration + selective GHS amplifies pulse amplitude
- Sustained 2–4 hour elevation, 2–4 ng/mL mean increase, youth-pattern pulse mimicry
- Minimal. No significant cortisol or prolactin co-secretion at standard doses
- Neutral. No ghrelin-mediated appetite stimulation
- Metabolic research, body composition studies, longevity protocols requiring GH benefits without appetite or cortisol complications
- Preferred for protocols prioritising clean endocrine profiles and repeatability without confounding appetite variables
- GHRP-6 Acetate
- Direct ghrelin receptor agonism. Forces GH secretion independent of GHRH pathway
- High-amplitude peak (15–25 ng/mL) within 30–45 min, returns to baseline in 3–4 hours
- Moderate. 30–50% cortisol elevation above baseline at therapeutic doses
- Strong. Subjective hunger increases 2–3× due to ghrelin mimicry
- Studies requiring maximal GH pulse amplitude, appetite stimulation research, cachexia models
- Delivers highest peak GH but requires appetite and cortisol management. Best when ghrelin effects are protocol-relevant rather than confounding
- Single-Agent CJC-1295 no DAC
- GHRH receptor agonism only
- Moderate amplitude, extended duration, lacks synergistic amplification without GHS co-administration
- Minimal
- Neutral
- GHRH pathway-specific research, baseline GH pulsatility studies
- Effective but underperforms combination therapy. Synergy with Ipamorelin produces measurably superior GH secretion profiles
- Single-Agent Ipamorelin
- Selective GHS-R1a agonism
- Moderate amplitude, standard pulse duration without GHRH analog support
- GHS pathway-specific research, protocols avoiding GHRH manipulation
- Clean GH secretion without cortisol. But combination with CJC-1295 no DAC increases efficacy 3–5× through dual-axis stimulation